Altimmune, Inc. (ALT) - Latest Market Data

Price & Market Data

Price: $5.31

Daily Change: +$0.04 / 0.75%

Daily Range: $5.17 - $5.50

Market Cap: $550,927,808

Daily Volume: 3,703,285

Performance Metrics

1 Week: -5.88%

1 Month: 30.05%

3 Months: 45.45%

6 Months: -23.14%

1 Year: -39.59%

YTD: -26.77%

Company Details

Employees: 59

Sector: Health technology

Industry: Biotechnology

Country:

Details

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Selected stocks

SunOpta, Inc. (STKL)

Maxeon Solar Technologies, Ltd. (MAXN)

Fusion Fuel Green PLC (HTOO)